Ultraviolet radiation downregulates allergy in BALB/c mice.
The immunosuppressive effects of exposure to ultraviolet radiation (UVR) are well known and the underlying mechanisms extensively studied. The suppression of Th1 appears to account for UVR suppression of contact hypersensitivity and delayed-type hypersensitivity responses and increased susceptibility to certain infections and tumor development. The underlying mechanisms suggest Th2-mediated responses associated with immediate-type hypersensitivity and allergic lung disease should be unchanged or possibly enhanced by UVR. The hypothesis that UVR exposure enhances allergic lung disease in BALB/c mice was tested. Effects of UVR on sensitization and elicitation of respiratory hypersensitivity were assessed using a fungal extract, Metarhizium anisopliae (MACA), as the allergen. BALB/c mice were sham or UVR (8 KJ/m(2)) exposed 3d before involuntary aspiration (IA) of MACA or vehicle. The mice received UVR exposures before the first and second of three IAs in the sensitization protocol and 3 d before the fourth IA in the elicitation protocol. Serum and bronchoalveolar lavage fluid (BALF) were harvested before (d 21, sensitization/d 24, elicitation) and at 1 (d 22/d 28), 3 (d 24/d 29), and 7 (d 28/d 35) d following the last IA. UVR exposure prior to sensitization suppressed two hallmarks of allergic disease, immune-mediated inflammation (eosinophil influx) and total immunoglobulin (Ig)E compared to the sham-UVR controls. There were no differences attributable to UVR exposure in previously sensitized mice. These data suggest that UVR exposure prior to sensitization suppresses allergic responses but has no effect on the elicitation of allergic responses in previously sensitized individuals. Consequently, there is no evidence that exposure to UVR enhances the induction or expression of allergic lung disease.
Ward
Marsha D W
MD
Office of Research and Development, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, 109 T.W. Alexander Drive, Mail Drop B143-04, Research Triangle Park, NC 27711, USA. ward.marsha@epa.gov
Sailstad
Denise M
DM
Andrews
Debora L
DL
Boykin
Elizabeth H
EH
Selgrade
MaryJane K
MK
D000818:Animals; D000946:Antigens, Fungal / Q000009:adverse effects; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000166:cytology / Q000276:immunology; D004195:Disease Models, Animal; D015536:Down-Regulation / Q000276:immunology / Q000528:radiation effects*; D004797:Enzyme-Linked Immunosorbent Assay; D004804:Eosinophils / Q000276:immunology; D005260:Female; D007073:Immunoglobulin E / Q000032:analysis / Q000097:blood; D007165:Immunosuppression Therapy / Q000379:methods*; D015847:Interleukin-4 / Q000097:blood; D015848:Interleukin-5 / Q000097:blood; D045022:Lactate Dehydrogenases / Q000032:analysis; D007958:Leukocyte Count; D051379:Mice; D008807:Mice, Inbred BALB C; D011506:Proteins / Q000032:analysis; D012130:Respiratory Hypersensitivity / Q000209:etiology / Q000276:immunology / Q000378:metabolism / Q000628:therapy*; D018417:Th1 Cells / Q000276:immunology / Q000528:radiation effects; D013997:Time Factors; D016896:Treatment Outcome; D014467:Ultraviolet Therapy / Q000379:methods*
D000946:Antigens, Fungal; D015848:Interleukin-5; D011506:Proteins; D015847:Interleukin-4; D007073:Immunoglobulin E; D045022:Lactate Dehydrogenases